OVERVIEW

We invite you to join us for the 1st Annual Best of Lung Cancer conference. This innovative and state of the art program will feature some of the world's leading lung cancer experts to present the latest research and strategies for the care of lung cancers — incorporating data from the major oncologic annual meetings.

Register free today to join the program virtually as our speakers present from Palm Beach, Florida.

LEARNING OBJECTIVES

• Describe current and evolving management strategies for patients with localized and locally advanced lung cancer.
• Identify best practices in biomarker testing and the utilization of biomarkers to drive treatment decisions for patients with lung cancer.
• Explain the application of targeted therapy and immunotherapy in the treatment of NSCLC.
• Outline the clinical trial data on the use of molecular drivers in the management of patients with advanced lung cancers.
• Summarize current and emerging strategies in the management of patients with advanced lung cancer without driver mutations.

ACCREDITATION

Amedco LLC designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For more information please visit the official event page.